Experimenter at tissue culture hood MI-mAbs

News

๐Ÿงช Heading to #AACR2025 and interested in advancing antibody discovery technologies?

Join us at ๐—ฃ๐—ผ๐˜€๐˜๐—ฒ๐—ฟ ๐—Ÿ๐—•๐Ÿฌ๐Ÿฌ๐Ÿฏ on ๐—ฆ๐˜‚๐—ป๐—ฑ๐—ฎ๐˜† ๐—”๐—ฝ๐—ฟ๐—ถ๐—น ๐Ÿฎ๐Ÿณ during the afternoon poster session where we will present our most recent data from MImAbs SAS.

 

๐Ÿ“Œ Highlight: We employed the ๐—•๐—ฒ๐—ฎ๐—ฐ๐—ผ๐—ปยฎ ๐˜€๐—ถ๐—ป๐—ด๐—น๐—ฒ-๐—• ๐—ฐ๐—ฒ๐—น๐—น ๐˜€๐—ฐ๐—ฟ๐—ฒ๐—ฒ๐—ป๐—ถ๐—ป๐—ด ๐—ฝ๐—น๐—ฎ๐˜๐—ณ๐—ผ๐—ฟ๐—บ to isolate novel monoclonal antibodies with ๐—ต๐—ถ๐—ด๐—ต ๐˜€๐—ฝ๐—ฒ๐—ฐ๐—ถ๐—ณ๐—ถ๐—ฐ๐—ถ๐˜๐˜† toward cancer-associated targets. Our approach enables rapid functional screening at the single-cell level, accelerating the path from B cell to candidate.

 

If you're interested in learning more or discussing potential collaborations, feel free to ๐—ฟ๐—ฒ๐—ฎ๐—ฐ๐—ต ๐—ผ๐˜‚๐˜ ๐˜๐—ผ ๐˜‚๐˜€ ๐˜๐—ผ ๐˜€๐—ฐ๐—ต๐—ฒ๐—ฑ๐˜‚๐—น๐—ฒ ๐—ฎ ๐—บ๐—ฒ๐—ฒ๐˜๐—ถ๐—ป๐—ด ๐—ฑ๐˜‚๐—ฟ๐—ถ๐—ป๐—ด ๐˜๐—ต๐—ฒ ๐—ฐ๐—ผ๐—ป๐—ณ๐—ฒ๐—ฟ๐—ฒ๐—ป๐—ฐ๐—ฒ weโ€™d be happy to connect!

 

#AACR2025 #AntibodyDiscovery #CancerResearch #SingleBCellScreening #BeaconPlatform #Bruker #ImmunoOncology #TranslationalResearch #MImAbs

  Back